Bilateral artery embolization for chronic migraine
Part of Brain & nervous system clinical trials.
This trial tests a procedure called bilateral middle meningeal artery embolization to see if it reduces chronic migraine symptoms in people who haven't found relief from other treatments. It's for those with frequent, disabling migraines that affect both sides of the head.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have chronic migraines (at least 15 headache days per month for over 3 months) that started before age 50 and affect both sides of your head.
- You have tried at least 2 different types of migraine prevention medications and they didn't work, or you couldn't take them.
- Your migraines have lasted for at least 12 months, and you've had them for at least 6 months after failing those 2 medication classes.
- You have not used opioid or barbiturate medications for migraines in the past year, and your MRI (done within 3 years) shows no other cause for your headaches.
- You can read and write in English and are able to sign your own consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows adults who undergo a procedure called middle meningeal artery embolization—a minimally invasive treatment that blocks blood flow to a specific artery thought to trigger migraines. The trial simply tracks your symptoms and quality of life before and after the procedure to understand how well it works.
This study tests a procedure that blocks a specific artery in the lining of the brain to see if it can reduce migraine attacks. If you have frequent migraines that haven't improved with medication, this might be a new option worth discussing with your doctor.
This trial tests a procedure that blocks a blood vessel in the head to see if it reduces chronic migraine pain. It might help people who have not found relief from other treatments.
This trial tests a new procedure that uses tiny coils to block a specific artery in the head, which may help reduce migraine attacks. It is for people who have tried at least two different preventive migraine medicines without success.
This trial tests whether using both a CGRP antibody and Botox together works better than the CGRP antibody alone for chronic migraine. It may help if you have not tried these treatments before.
This study tests a procedure called MMA embolization (blocking a small artery in the head) to see if it can reduce migraine attacks in people with chronic, hard-to-treat migraines.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.